Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Why Sanmina (SANM) is a Top Value Stock for the Long-Term
Why Sanmina (SANM) is a Top Value Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Are Finance Stocks Lagging  Atlanticus (ATLC) This Year?
Are Finance Stocks Lagging Atlanticus (ATLC) This Year?

Investors interested in Finance stocks should always be looking to find the best-performing companies in the group. Atlanticus Holdings Corporation (ATLC) is a stock that can certainly grab the

Here's Why Ollie's Bargain Outlet (OLLI) is a Strong Value Stock
Here's Why Ollie's Bargain Outlet (OLLI) is a Strong Value Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

Are Investors Undervaluing Amadeus IT Group (AMADY) Right Now?
Are Investors Undervaluing Amadeus IT Group (AMADY) Right Now?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

Here's Why DocuSign (DOCU) is a Strong Value Stock
Here's Why DocuSign (DOCU) is a Strong Value Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock?Photo, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock?

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always

Here's Why Goldman Sachs (GS) is a Strong Value Stock
Here's Why Goldman Sachs (GS) is a Strong Value Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

Are Investors Undervaluing VAREX IMAGING (VREX) Right Now?
Are Investors Undervaluing VAREX IMAGING (VREX) Right Now?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

Here's Why Kinsale Capital Group, Inc. (KNSL) is a Strong Value Stock
Here's Why Kinsale Capital Group, Inc. (KNSL) is a Strong Value Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

Are Investors Undervaluing Archer Daniels Midland (ADM) Right Now?
Are Investors Undervaluing Archer Daniels Midland (ADM) Right Now?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

Here's Why Labcorp Holdings (LH) is a Strong Value Stock
Here's Why Labcorp Holdings (LH) is a Strong Value Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Are Medical Stocks Lagging  Assertio (ASRT) This Year?Photo, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Are Medical Stocks Lagging Assertio (ASRT) This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Assertio (ASRT) one of those stocks right now? Let's take a

Why GSK (GSK) is a Top Value Stock for the Long-Term
Why GSK (GSK) is a Top Value Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Is Arista Networks (ANET) Stock Outpacing Its Computer and Technology Peers This Year?
Is Arista Networks (ANET) Stock Outpacing Its Computer and Technology Peers This Year?

Investors interested in Computer and Technology stocks should always be looking to find the best-performing companies in the group. Arista Networks (ANET) is a stock that can certainly grab the

Are Consumer Discretionary Stocks Lagging  Sirius XM (SIRI) This Year?
Are Consumer Discretionary Stocks Lagging Sirius XM (SIRI) This Year?

The Consumer Discretionary group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Sirius XM (SIRI) is a stock that can certainly

Should Value Investors Buy Broadwind Energy (BWEN) Stock?
Should Value Investors Buy Broadwind Energy (BWEN) Stock?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

Are Investors Undervaluing Banco Santander (SAN) Right Now?
Are Investors Undervaluing Banco Santander (SAN) Right Now?

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always

Is Braskem (BAK) Stock Outpacing Its Basic Materials Peers This Year?
Is Braskem (BAK) Stock Outpacing Its Basic Materials Peers This Year?

The Basic Materials group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Braskem (BAK) one of those stocks right now? Let's

Viavi Q3 Earnings Surpass Estimates on Healthy Top-Line Growth
Viavi Q3 Earnings Surpass Estimates on Healthy Top-Line Growth

Viavi Solutions Inc. VIAV reported strong third-quarter fiscal 2026 results, with both top and bottom lines surpassing the Zacks Consensus Estimate.The company posted a solid 42.8% year-over-year

Onto Innovation Likely to Beat on Q1 Earnings: Buy the Stock Now?
Onto Innovation Likely to Beat on Q1 Earnings: Buy the Stock Now?

Onto Innovation ONTO is set to report earnings for the first quarter of 2026 on May 5, after the closing bell.

The Zacks Consensus Estimate for first-quarter earnings per share (EPS) is pinned at

K12 (LRN) Just Overtook the 20-Day Moving Average
K12 (LRN) Just Overtook the 20-Day Moving Average

After reaching an important support level, K12 (LRN) could be a good stock pick from a technical perspective. LRN surpassed resistance at the 20-day moving average, suggesting a short-term bullish

Celestica (CLS) Crossed Above the 20-Day Moving Average: What That Means for Investors
Celestica (CLS) Crossed Above the 20-Day Moving Average: What That Means for Investors

From a technical perspective, Celestica (CLS) is looking like an interesting pick, as it just reached a key level of support. CLS recently overtook the 20-day moving average, and this suggests a

After Plunging 27.4% in 4 Weeks, Here's Why the Trend Might Reverse for Purple Innovation (PRPL)
After Plunging 27.4% in 4 Weeks, Here's Why the Trend Might Reverse for Purple Innovation (PRPL)

Purple Innovation (PRPL) has been beaten down lately with too much selling pressure. While the stock has lost 27.4% over the past four weeks, there is light at the end of the tunnel as it is now in

Down 9.2% in 4 Weeks, Here's Why CGI (GIB) Looks Ripe for a Turnaround
Down 9.2% in 4 Weeks, Here's Why CGI (GIB) Looks Ripe for a Turnaround

A downtrend has been apparent in CGI Group (GIB) lately with too much selling pressure. The stock has declined 9.2% over the past four weeks. However, given the fact that it is now in oversold

Company News for Apr 30, 2026
Company News for Apr 30, 2026
  • Amphenol Corporation’s APH shares rose 3.2% after reporting first-quarter 2026 adjusted earnings of $1.06 per share, beating the Zacks Consensus Estimate of 95 cents.
  • Shares of Visa Inc. V jumped